Hypofractionated Radiotherapy: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Hypofractionated Radiotherapy

• A Phase II Study of Pirfenidone Plus PD-1 Inhibitor With or Without Hypofractionated Radiotherapy for Refractory pMMR/MSS Colorectal Cancer
  NCT07644286 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment
  NCT03829553 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer
  NCT06435260 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving Surgery
  NCT04025164 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: Female · 5 locations
• Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction
  NCT07084519 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC
  NCT06379087 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer
  NCT04636008 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Hypofractionated Radiotherapy?

7 recruiting trials across 13 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.